Lower Costs, More Paperwork: New Barriers to Prescription Drugs
Chart of the Day: Medicare, Medicaid, and Insurers Replaced High Costs With More Hurdles, LDI Expert Finds
In Their Own Words
This Doctor Spends Hours Talking to Insurers. Her Patients Suffer The Most.
Prior Authorizations Were Meant to Cut Costs. Now They Delay Care, Says CHOP Rheumatologist
Print:
The following excerpt is from an op-ed that first appeared in the Philadelphia Inquirer on February 28th, 2024.
My patient — we’ll call her Sydney — was a young teenager who had been sick for weeks. We ultimately diagnosed her with an aggressive, rare disorder of the blood vessels that can restrict blood flow and damage vital organs.
Sydney received Remicade, a targeted, immunosuppressive medication known as a biologic during her hospitalization, and it worked. Her fevers abated, her energy returned, and her labs showed dramatic improvement. Yet, despite Sydney’s visible improvement during her hospital stay, her insurance provider denied payment for her Remicade treatments when she went home.
After an initial letter explaining the necessity of her medication, followed by a 75-minute phone call with Sydney’s insurance company three weeks later, we ultimately got her medication approved, four weeks after we prescribed it. Fortunately, Sydney was only one day late for her monthly dose.
Unfortunately, I have many other patients whose struggles with insurance over medication coverage haven’t ended so well.
As a pediatric rheumatologist, I care for children with rare forms of chronic illness for which we now have highly effective therapies. But too often, my patients can’t access these effective therapies because insurers put up many barriers to coverage.
Read the entire op-ed here.
Author
Dori Abel, MD
Fellow, Pediatric Rheumatology, Children’s Hospital of Philadelphia
More on Health Care Access & Coverage
Cost Plus Drugs Beats Health Insurance for High-Cost Generics
Chart of the Day: Mark Cuban’s Cost Plus Drugs Can Save Employer-Covered Patients Hundreds on Some Generics
Debate Continues Over H.R. 1 Medicaid Changes as Millions Risk Losing Coverage
Will Implementation Create Sweeping Losses or a Return to Balance and Self-Sufficiency?
Insurers Should Incentivize Non-Drug Treatments for Chronic Pain
An LDI Fellow and Chronic Pain Researcher Call on Health Plans To Lower Barriers to Physical Therapy, Acupuncture, and Interdisciplinary Pain Care
Medicaid Reviews May Disenroll Vulnerable Dual Eligibles
Chart of the Day: Researchers Urge Easier Renewals and Better Support To Prevent Gaps in Care
New Study Reveals Death Rates During SSDI’s 24-Month Wait for Medicare
While They Wait for Medicare, People Approved for Social Security Disability Die at Higher Rates Compared to the General Public